Search research articles
Contact Us
Filters
Showing results (51-60 of 123) with videos related to
Page
of 13
Sort By:
Obstetrics and Gynecology
|
November 1, 1988
Renal metastases of gestational trophoblastic disease: a report of eight cases
J T Soper, D G Mutch, N Chin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1990
Transperineal templates for brachytherapy treatment of pelvic malignancies--a comparison of standard and customized templates
G C Bentel, J R Oleson, D Clarke-Pearson, et al.
Obstetrics and Gynecology
|
March 1, 1994
Preoperative coagulation testing on a gynecologic oncology service
E R Myers, D L Clarke-Pearson, G J Olt, et al.
International Journal of Cancer
|
November 15, 1987
Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer
F Leoni, R C Bast, S Canevari, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1992
Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease
G P Sutton, J T Soper, J A Blessing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study
S S Lentz, M F Brady, F J Major, et al.
Cancer
|
September 1, 1990
Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center
D G Mutch, J T Soper, C J Babcock, et al.
Gynecologic Oncology
|
May 19, 2007
Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer
N Calloway Rankins, A Alvarez Secord, E Jewell, et al.
Gynecologic Oncology
|
December 1, 1993
Prevention of superficial wound separation with subcutaneous retention sutures
A P Soisson, G Olt, J T Soper, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1987
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging
J T Soper, R H Wilkinson, L C Bandy, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 123) with videos related to
Sort By:
Page
of 13
Obstetrics and Gynecology
|
November 1, 1988
Renal metastases of gestational trophoblastic disease: a report of eight cases
J T Soper, D G Mutch, N Chin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1990
Transperineal templates for brachytherapy treatment of pelvic malignancies--a comparison of standard and customized templates
G C Bentel, J R Oleson, D Clarke-Pearson, et al.
Obstetrics and Gynecology
|
March 1, 1994
Preoperative coagulation testing on a gynecologic oncology service
E R Myers, D L Clarke-Pearson, G J Olt, et al.
International Journal of Cancer
|
November 15, 1987
Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer
F Leoni, R C Bast, S Canevari, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1992
Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease
G P Sutton, J T Soper, J A Blessing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study
S S Lentz, M F Brady, F J Major, et al.
Cancer
|
September 1, 1990
Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center
D G Mutch, J T Soper, C J Babcock, et al.
Gynecologic Oncology
|
May 19, 2007
Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer
N Calloway Rankins, A Alvarez Secord, E Jewell, et al.
Gynecologic Oncology
|
December 1, 1993
Prevention of superficial wound separation with subcutaneous retention sutures
A P Soisson, G Olt, J T Soper, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1987
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging
J T Soper, R H Wilkinson, L C Bandy, et al.
Page
of 13